| Registered Number | 4763064 |
|---|---|
| Registered Address |
Precision House Arden Road Alcester Warwickshire B49 6HN |
| Head Office |
Leconfield House Curzon Street London B49 6HN |
| Phone Number | +44 (0) 1789 761020 |
| Fax Number | |
| Website | http://www.melroseplc.net |
| Activities | Provides engineering services |
| Country of Register | GB |
| Currency | GBX |
| Short Name | MELROSE |
| First Day Traded | 09/08/2011 |
| Industrial Sector | Steel |
| Number of shares | 391m |
| Christopher Miller | Chairman |
|---|---|
| David Roper | Chief Executive Officer |
| Miles Templeman | Non Executive Director |
| Simon Peckham | Director |
| John Grant | Non Executive Director |
| Geoffrey Martin | Financial Director |
| Justin Dowley | Non Executive Director |
| BlackRock Investment Management (UK) Ltd. | 11.33% |
|---|---|
| Threadneedle Asset Management Ltd. | 7.36% |
| Director | Date | Buy/Sell | Quantity | Price |
|---|---|---|---|---|
You need to be a Selfrade customer to access this data. |
||||
| AR 2007 | AR 2008 | AR 2009 | AR 2010 | AR 2011 | |
| Fiscal Year End | 31/12/2007 | 31/12/2008 | 31/12/2009 | 31/12/2010 | 31/12/2011 |
| Duration (months) | 12 | 12 | 12 | 12 | 12 |
| Accounting Format | IFRS | IFRS | IFRS | IFRS | IFRS |
| Sales/Revenue | 344 | 938.30 | 1,298.50 | 1,379.50 | 1,153.90 |
| Cost of Goods Sold (COGS) incl. D&A | 280.10 | 710.10 | 997 | 1,015.10 | 836.60 |
| COGS excluding D&A | 267.70 | 675.30 | 936.70 | 955.60 | 789.80 |
| Depreciation & Amortization Expense | 12.40 | 34.80 | 60.30 | 59.50 | 46.80 |
| Depreciation | 10.30 | 20.70 | 32.70 | 32 | 22.50 |
| Amortization of Intangibles | 2.10 | 14.10 | 27.60 | 27.50 | 24.30 |
| Amortization of Deferred Charges | 0 | 0 | 0 | 0 | 0 |
| Gross Income | 63.90 | 228.20 | 301.50 | 364.40 | 317.30 |
| Selling, General & Administrative Expense | 41.40 | 142.10 | 178.50 | 193.70 | 160.20 |
| Research & Development | 0 | 1.80 | 2.40 | 2.40 | 2 |
| Other Selling, General & Administrative | 41.40 | 140.30 | 176.10 | 191.30 | 158.20 |
| Other Operating Expense | 0 | 0 | 0 | 0 | 0 |
| Non Operating Income/Expense | 0 | -3.40 | -8.60 | -6 | -1.40 |
| Non-Operating Interest Income | 6.80 | 4.90 | 5.10 | 9.30 | 10 |
| Equity in Affiliates (Pretax) | 0 | 0 | 0 | 0 | 0 |
| EBIT | 0 | 0 | 0 | 0 | 0 |
| Unusual Expense | 3.80 | 36.30 | 10.30 | -11.30 | 40.10 |
| EBIT after Unusual Expense | 0 | -36.30 | -10.30 | 0 | 0 |
| Interest Expense | 4.30 | 25.20 | 27.60 | 29.60 | 28.20 |
| Gross Interest Expense | 4.30 | 25.20 | 27.60 | 29.60 | 28.20 |
| Interest Capitalized | 0 | 0 | 0 | 0 | 0 |
| Pretax Income | 21.20 | 26.10 | 81.60 | 155.70 | 97.40 |
| Income Tax | 5.60 | 10.10 | 27.30 | 14 | -17.40 |
| Income Tax - Current Domestic | 6.60 | 21.10 | 26.20 | 28.80 | -5.90 |
| Income Tax - Current Foreign | 0 | 0 | 0 | 0 | 0 |
| Income Tax - Deferred Domestic | -1 | -11 | 1.10 | -14.80 | -11.50 |
| Income Tax - Deferred Foreign | 0 | 0 | 0 | 0 | 0 |
| Income Tax Credits | 0 | 0 | 0 | 0 | 0 |
| Minority Interest Expense | 0.20 | 0.50 | -0.20 | 0.20 | 0.10 |
| Equity in Affiliates | 0 | -0.10 | 0.40 | -0.40 | 0 |
| Other After Tax Income (Expense) | 0 | 0 | 0 | 0 | 0 |
| Net Income | 15.40 | 15.40 | 54.90 | 141.10 | 114.70 |
| Extraordinaries & Discontinued Operations | 398.80 | -63.50 | 24.60 | 0 | 171.70 |
| Extra Items & Gain/Loss Sale Of Assets | 199.40 | -39.90 | 9.70 | 0 | 152.40 |
| Cumulative Effect - Accounting Chg | 0 | 0 | 0 | 0 | 0 |
| Discontinued Operations | 199.40 | -23.60 | 14.90 | 0 | 19.30 |
| Net Income After Extraordinaries | 414.20 | -48.10 | 79.50 | 141.10 | 286.40 |
| Preferred Dividends | 0 | 0.20 | 0 | 0 | 0 |
| Net Income available to Common | 15.40 | 15.20 | 54.90 | 141.10 | 114.70 |
| Operational EPS | 10.48 | 16.38 | 15.56 | 32.42 | 29.41 |
| EPS (basic) | 128.45 | -3.39 | 17.82 | 36.15 | 29.40 |
| EPS (diluted) | 8.94 | 6.13 | 13.75 | 34.34 | 23.63 |
| EBITDA | 34.90 | 120.90 | 183.30 | 230.20 | 203.90 |
| EBIT | 0 | 0 | 0 | 0 | 0 |
| +Depreciation & Amortization Expense | 12.40 | 34.80 | 60.30 | 59.50 | 46.80 |